来自红树林植物的植物化学物质的抗癌潜力:全面的机制性见解
Raihan Chowdhury1,2, Md Shimul Bhuia1,2, Md Sakib Al Hasan1
1Department of Pharmacy Bangabandhu Sheikh Mujibur Rahman Science and Technology University Gopalganj Bangladesh.
Food science & nutrition
|November 18, 2024
概括
红树林植物及其化合物显示出显著的抗癌潜力. 研究强调了它们通过各种分子机制对抗癌症的能力,这表明它们是新药开发的关键因素.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 癌症是全球死亡的主要原因,其特点是不受控制的细胞生长和转移.
- 由于副作用较少和活性较强,正在探索植物性天然化合物作为抗癌疗法.
- 红树林植物具有多样化的生物活动,包括抗炎和抗氧化特性.
研究的目的:
- 审查红树林植物及其衍生化合物作为潜在的抗癌剂.
- 强调其抗癌作用背后的分子机制.
- 巩固其疗效的临床前证据.
主要方法:
- 从2000年到2023年进行的临床前 (体外和体内) 研究的系统文献综述.
- 在主要的科学数据库 (PubMed,Scopus,科学网等) 进行的搜索. ) 的情况.
- 分析的重点是确定了分子作用机制.
主要成果:
- 在临床前模型中,红树林衍生化合物表现出有前途的抗癌特性.
- 机制包括诱导氧化应激,线粒体功能障碍和亡.
- 其他观察到的效应包括细胞毒性,基因毒性,细胞循环停止和抗增殖/抗转移作用.
结论:
- 红树林植物及其化合物显示出作为新型抗癌药物开发来源的巨大潜力.
- 对它们分子通路的进一步研究可以加速治疗应用.
- 这些天然药物为癌症治疗策略提供了一个有希望的途径.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Electron Transport Chain: Complex I and II
11.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.9K


